Results 181 to 190 of about 38,480 (291)

Assessment of the Anticoagulation Activity of Apixaban

Circulation Journal, 2015
Fernando Araújo, Luciana Ricca Gonçalves   +1 more
openaire   +4 more sources

Acute Renal Artery Thrombosis Following Delayed Postoperative Anticoagulation in Atrial Fibrillation: A Case Report Supporting Apixaban Monotherapy. [PDF]

Cureus
Kureemun MR, Rahemtoola MS, Husein AAI, Dalmia S.   +3 more
europepmc   +1 more source

Comparison of Apixaban with Warfarin for the Prevention of Subclinical Cerebral Infarction after Direct Current Cardioversion in Patients with Atrial Fibrillation. [PDF]

Chonnam Med J
Kim C, Lee KH, Lee YH, Park HW, Yoon NS, Kim SK.   +5 more
europepmc   +1 more source

Cost‑effectiveness analysis of apixaban versus other NOACs for the prevention of stroke in Italian atrial fibrillation patients

, 2014
Lorenzo Pradelli, Mario Calandriello, Roberto Di Virgilio, Marco Bellone, Marco Tubaro   +4 more
openalex   +2 more sources

Four-factor prothrombin complex concentrate (Beriplex® P/N) mediated reversal of apixaban-induced bleeding in a rabbit model [PDF]

, 2015
Eva Herzog, Franz Kaspereit, Wilfried Krege, Jochen Mueller‐Cohrs, Baerbel Doerr, Peter Niebl, Gerhard Dickneite   +6 more
openalex   +1 more source

Resolution of Ascending Aorta and Pulmonary Vein Thrombi With Apixaban Therapy: A Case Study. [PDF]

Cureus
Takeuchi H.
europepmc   +1 more source

Response to ‘Re: Kakkos et al. Efficacy and Safety of the New Oral Anticoagulants Dabigatran, Rivaroxaban, Apixaban, and Edoxaban in the Treatment and Secondary Prevention of Venous Thromboembolism: A Systematic Review and Meta-analysis of Phase III Trials’

, 2014
Stavros K. Kakkos, George Kirkilesis, Ioannis A. Tsolakis   +2 more
openalex   +1 more source

Efficacy and Safety of Apixaban Compared With Warfarin in Patients With Atrial Fibrillation in Relation to Renal Function Over Time [PDF]

, 2016
Ziad Hijazi, Stefan H. Hohnloser, Ulrika Andersson, John H. Alexander, Michael Hanna, Mátyás Keltai, Alexander Parkhomenko, José López‐Sendón, Renato D. Lópes, Agneta Siegbahn, Christopher B. Granger, Lars Wallentin   +11 more
openalex   +1 more source

Comparative safety and effectiveness of apixaban and rivaroxaban for treatment of cancer-associated venous thromboembolism: A retrospective cohort study. [PDF]

PLoS Med
Sun J, Mehta HB, Segal JB, Alexander GC.
europepmc   +1 more source

Does the current apixaban dosing strategy adequately fit and ensure safety in Korean patients with atrial fibrillation? [PDF]

Blood Res
Kim B.
europepmc   +1 more source